Full Archive

A lesson learned?

Albert Einstein stated that failure is success in progress. When it comes to digital health, we hope that’s true as so far all we have seen is failure. COVID provided the opportunity and resources digital health needed to move to the front of the line. Yet as we kept saying for digital health to remain at the front it would have to prove its value after COVID was gone. Well,...

Diabetes a change agent

It may seem implausible to some, but the fact is diabetes device and drug technology is changing the way people manage their health. Right this very moment we are in the midst of the latest weight lost craze since Oprah bought weight watchers. Drugs originally created and intended for patients with Type 2 diabetes have become the hottest commodity on the street generating mass attention. The difference between this weight loss...

Useless Knowledge

Another post you can share as you like. A report published in the Annal of Internal Medicine entitled Prevalence and Correlates of Patient Rationing of Insulin in the United States: A National Survey is getting lots of attention in the mainstream diabetes unaware media. This study indicates that 1.3 million insulin using patients rationed their insulin. But here’s the kicker the study did not look at or examine if there were...

Has Insulin become BGM?

Don’t ask why but decided to take a look at the results Roche released maybe I wanted a trip down memory lane. Yes, Abbott reported as well and yes, the results came in as expected so nothing really newsworthy there. Yet looking at the Roche results made me think of two relevant ideas – first while CGM is taking over the glucose monitoring world BGM is still alive and kicking...

Not Today

Just in case anyone missed it on the Today show they covered the hottest topic in Tinseltown Hollywood’s obsession with Ozempic. Yes, thanks to Tik Toc and other forms of social media the rest of the world knows what we’ve been saying for some time now that the fight against fat could very well be the best thing ever for diabetes. This isn’t just good news for Novo Nordisk the...

Sitting on the Iron Throne

Long time readers of Diabetic Investor have come to learn our mantra that in the end talent wins and in our wacky world talent is in short supply. But talent is not just the man or woman who sits in the executive suite, talent extends to the team they have assembled and the direction they have been given. We have also consistently noted that a talented company will put the patient...

Why they fail

Before we get started today this is one of those rare posts that you can share with anyone and not violate the Diabetic Investor copyright. As everyone knows there are a plethora of statistics when it comes to diabetes. Diabetes continues to grow at epidemic rates and continues to be not just a healthcare crisis but an economic crisis as well. While many advances have been made over the years for...